A Post-marketing Study to Evaluate a Novel Surgical Monitoring Technique Using the EARP Nerve Cuff in TLIF Surgery.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-07

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the differences (the effectiveness and the safety) between two different nerve and muscle monitoring devices currently available during a TLIF surgery.

The Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and Retractor surgical and nerve monitoring tools will be used in addition to standard nerve monitoring tools during the surgery. The choice of standard nerve monitoring equipment is based on the decision of the surgeon and technologist and is not dictated by this study.

These tools will be compared with regards to safety and ability to accurately monitor the nervous system during the surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Objective of the Protocol is to Generate Real World Evidence (RWE) Supporting the Safety, Performance, and Health Economics of Using the Regulatory Approved and Commercially Available EARP Interbody System Used During Lumbar Interbody Fusion (LIF) Procedures With the EARP Nerve Cuff Electrode

NCT07020000

Transforaminal Lumbar Interbody Fusion Surgery

NOT_YET_RECRUITING

Multimodality Neuromonitoring in XLIF

NCT01499680

Degeneration of Lumbar Intervertebral Disc

COMPLETED

Advanced XLIF Monitoring Multicenter Study

NCT02272140

Degenerative Lumbar Disc Disease

COMPLETED

Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure

NCT05648474

Intervertebral Disc Degeneration Stenosis, Spinal Spondylolisthesis +2 more

RECRUITING

Transcutaneous Auricular Neurostimulation After Lumbar Surgery

NCT06100172

Pain, Postoperative Opioid Use Lumbar Spine Injury

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The application of traditional SSEPs and tcMEPs to lumbar nerve root monitoring during TLIF surgery is both challenging and problematic. When applied to lumbar nerve root monitoring, SSEPs and tcMEPs unfortunately suffer in specificity, sensitivity, or both. A surgeon thus cannot confidently rely on these techniques to monitor nerve root function and must guess the likelihood of dysfunction.

Spontaneous EMG (sEMG) is also used to monitor nerve root activity. While sEMG is an excellent indicator of spinal nerve root manipulation, it is a poor diagnostic indicator of dysfunction. 90-95% of sEMG alerts are not associated with dysfunction yielding a high false positive rate and poor specificity, and postoperative deficits are often not associated with sEMG alerts yielding many false negatives and poor sensitivity. The primary utility of sEMG is to use as an indicator of manipulation, which prompts the acquisition of tcMEPs to assess function.

There is a clear need to take the guesswork out of monitoring the functional status of nerve roots at risk during lumbar decompressions and select interbody fusions. During TLIFs, the exiting nerve root is at risk as it courses obliquely across disc space encroaching on the surgical corridor. Standardly, a hand-held retractor is used to retract and protect the nerve root during disc space preparation, implant insertion or even simple decompression. This maneuver and retraction place a particular nerve root at risk, but again, traditional SSEP and tcMEPs are not ideal for monitoring that risk.

The EARP Nerve Cuff Electrode (Retropsoas Technologies) is a novel, Class II, device that is 510(k) cleared by FDA. It conducts electrical signals as a component of intraoperative neuromonitoring, is used with commercially available neuromonitoring systems, and does not stimulate or record the signal itself. The standard connectors at the proximal end interface with the neuromonitoring equipment. The distal nerve cuff electrode partially encircles and contacts the target nerve root. It uses a bipolar configuration to limit current spread. It is available in several inner diameters to accommodate variability in patient nerve root size anatomy.

The EARP Retractor is a Class I device used with a commercially available Retractor system and is only used as an additional 4th blade.

In TLIF surgery, the exiting nerve must be retracted to allow for sufficient access to the intervertebral disc space. The retraction is applied at the medial portion of the nerve root. The application of this retraction may produce activity in the nerve root and/or conduction changes in the nerve root due to temporary manipulation, compression, or ischemia related to the retraction.1

The objective of the study is to demonstrate the ability to safely monitor lumbar nerve root activity and function during retraction using an Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and an EARP Retractor system during a standard Transforaminal Lumbar Interbody Fusion (TLIF), with improved specificity and sensitivity over traditional monitoring techniques.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transforaminal Lumbar Interbody Fusion Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Undergoing a single-level or two-level TLIF between L2-S1

During the surgery, the standard monitoring devices and the EARP monitoring study devices and techniques will be used.

Group Type EXPERIMENTAL

Nerve Cuff and Retractor System

Intervention Type DEVICE

Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and an EARP Retractor system to safely monitor lumbar nerve root activity and function during a standard Transforaminal Lumbar Interbody Fusion (TLIF).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nerve Cuff and Retractor System

Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and an EARP Retractor system to safely monitor lumbar nerve root activity and function during a standard Transforaminal Lumbar Interbody Fusion (TLIF).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Undergoing TLIF between L2-S1

Exclusion Criteria

* Requiring TLIF surgery only at the L5-S1 level
* Acute lumbar spine trauma requiring immediate intervention
* Allergy or contraindication to propofol
* Lower extremity amputation
* Significant lower extremity edema noted on clinical exam
* Current treatment with chemotherapy, radiation, or immunosuppression
* Pregnant, or plans on becoming pregnant in the near future
* History of allergy to titanium, platinum, aluminum, stainless steel, or silicon

Minimum Eligible Age

22 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No